QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director

Ness Zio a, Is ael, July 17, 2026 (GLOBE NEWSWIRE) — QTREX Qua tum Ltd. (Nasdaq: QTEX) (“QTREX” o the “Compa y”), a compa y focused o adva ci g Additively Ma ufactu ed Elect o ics (“AME”) fo qua tum computi g i f ast uctu e, today a ou ced that o July 14, 2026, its Boa d of Di ecto s (the “Boa d”) appoi ted D . Shlomit Chappel-Ram as a i depe de t di ecto , effective immediately.

D . Chappel-Ram p eviously se ved as Vice P eside t of R&D at Na o Dime sio Ltd. (Nasdaq: NNDM), whe e she led multidiscipli a y teams spa i g mate ials, fo mulatio s, chemist y, physics, p ocess e gi ee i g, mecha ics, softwa e, ha dwa e, a d elect o ics. She also co-autho ed pee – eviewed IEEE esea ch o AME-fab icated, multi-metal-laye a te a a chitectu es.

As p eviously a ou ced, QTREX acqui ed the AME platfo m f om Na o Dime sio Ltd. i Ap il 2026 a d is applyi g it to high-de sity, the mally optimized qua tum co ectivity a d p op ieta y, applicatio -specific RF compo e ts. D . Chappel-Ram’s appoi tme t adds di ect AME ope ati g expe ie ce to the Boa d as QTREX adva ces its platfo m f om a validated capability i to comme cial compo e t p oductio .

“We a e addi g to ou Boa d a executive who played a fou datio al ole i developi g AME tech ology a d fully ecog izes the value it b i gs to qua tum computi g i f ast uctu e,” said Dagi Be -Noo , Chief Executive Office of QTREX Qua tum. “D . Chappel-Ram’s deep tech ical u de sta di g a d p ove t ack eco d i scali g complex ha dwa e di ectly match the ope atio al phase QTREX is at today.”

D . Chappel-Ram has se ved as a Ge e al Ma age of Digma Medical si ce Ja ua y 2025, whe e she leads ope atio s, p oduct developme t, egulato y a d cli ical p og ams, fu d aisi g, a d i vesto commu icatio s. F om Ja ua y 2021 u til Decembe 2024 she also se ved as Digma Medical’s Vice P eside t R&D a d was leadi g I vesto Relatio s activities. She p eviously held se io R&D oles at Edwa ds Lifescie ces (Ca dioba d) a d Medi ol Ltd., alo gside he te u e at Na o Dime sio Ltd. f om Ma ch 2019 u til Decembe 2020, whe e she di ected complex tech ology p og ams f om ea ly-stage developme t th ough egulato y app oval a d t a sfe to ma ufactu i g. D . Chappel-Ram se ves as a co sulta t a d adviso y boa d of di ecto s’ membe at Kid o Capital si ce Ap il 2021, a d also se ved as a co sulta t a d adviso y boa d of di ecto membe at NGLi Holdi gs f om Ma ch 2023 u til Ma ch 2024. He academic a d p ofessio al t ai i g i cludes a Ph.D. i Chemist y, summa cum laude, a d a MBA f om Ba -Ila U ive sity, postdocto al wo k i Chemist y a d Biochemist y at the City U ive sity of New Yo k, a d completio of the Di ecto s a d Se io Co po ate Officeholde s P og am at Tel Aviv U ive sity’s LAHAV Executive Educatio .

“I have see fi stha d what AME ca delive whe mate ials, elect ical desig a d ma ufactu i g a e e gi ee ed as o e i teg ated system,” said D . Chappel-Ram. “QTREX is applyi g these capabilities to the dema di g co ectivity equi eme ts of scalable qua tum ha dwa e, a d I look fo wa d to co t ibuti g my expe ie ce as the Compa y adva ces developme t, qualificatio a d comme cial p oductio .”

About QTREX Qua tumQTREX Qua tum Ltd. (Nasdaq: QTEX) is a tech ology compa y focused o adva ced co ectivity a d elect o ics ma ufactu i g solutio s fo ext-ge e atio ha dwa e ma kets. Followi g its acquisitio of the AME platfo m, the Compa y is developi g high-de sity, the mally optimized qua tum co ectivity solutio s fo dilutio c yostats a d adva ci g AME applicatio s fo defe se, ae ospace, missile, space, a d othe missio -c itical e vi o me ts. The Compa y also co ti ues to adva ce its medical tech ology po tfolio, i cludi g espi ato y suppo t a d blood mo ito i g platfo ms, while actively wo ki g to mo etize ce tai pa ts of the medical busi ess.

Fo mo e i fo matio , please visit: q-t ex.com

Fo wa d-Looki g Stateme t Disclaime This p ess elease co tai s exp ess o implied fo wa d-looki g stateme ts pu sua t to U.S. Fede al secu ities laws. These fo wa d-looki g stateme ts a e based o the cu e t expectatio s of the ma ageme t of the Compa y o ly a d a e subject to facto s a d u ce tai ties that could cause actual esults to diffe mate ially f om those desc ibed i the fo wa d-looki g stateme ts. Fo example, the Compa y is usi g fo wa d-looki g stateme ts whe it discusses the AME platfo m capabilities a d adva ces; that D . Chappel-Ram’s appoi tme t adds di ect AME ope ati g expe ie ce to the Boa d; that D . Chappel-Ram’s deep tech ical u de sta di g a d p ove t ack eco d i scali g complex ha dwa e di ectly match the ope atio al phase QTREX is at today; a d the belief that D . Chappel-Ram will co t ibute he expe ie ce as the Compa y adva ces developme t, qualificatio a d comme cial p oductio . Except as othe wise equi ed by law, the Compa y u de takes o obligatio to publicly elease a y evisio s to these fo wa d-looki g stateme ts. Mo e detailed i fo matio about the isks a d u ce tai ties affecti g the Compa y is co tai ed u de “Risk Facto s” i the Compa y’s a ual epo t o Fo m 20-F fo the fiscal yea e ded Decembe 31, 2025, filed with the U.S. Secu ities a d Excha ge Commissio .

Compa y Co tactQTREX Qua tumEmail: i fo@q-t ex.comPho e: +972-9-9664485